FeyeCon Development

FeyeCon is a premier technology provider specializing in the development and implementation of supercritical carbon dioxide (scCO2) processes for the life sciences, pharmaceutical, and food industries. The company offers innovative solutions for drug formulation, including micronization, the creation of liposomes, and the development of controlled-release delivery systems without the use of organic solvents. Their technology is also applied to the sterilization of medical devices and the extraction of high-value bioactive compounds. FeyeCon operates as an incubator and R&D partner, frequently spinning out specialized companies to commercialize specific applications of its CO2 platform. The company's sustainable approach provides a green alternative to traditional chemical processing, enhancing product purity and reducing environmental impact.